Global pharma major AstraZeneca announced late on Tuesday evening that it was putting a halt on ongoing clinical trials for a coronavirus vaccine it is developing in collaboration with Oxford University. Oxford University, where the vaccine was developed, said in a separate statement that the nature of the illness can not be revealed "for reasons of participant confidentiality". An AP poll taken in May found only about half said they would get a COVID-19 vaccine. Late-stage trials had been paused after the study subject fell in Britain.
"The CEO of U.S. pharmaceutical giant Pfizer was also upbeat about the prospect that U.S. citizens could well see the beginnings of a Covid vaccine by year end", he added.
As per the news release by AstraZeneca, it was clearly said that trials for the vaccine have been put on hold because of a potential unexplained illness.
Soriot said the diagnosis would be submitted to an independent safety committee and this would usually then tell the company whether trials can be resumed.
The multinational pharmaceutical company had been testing a potential vaccine in the United Kingdom, where a volunteer suffered a severe possible side effect.
Apple Drops iOS 14, New iPads, Apple Watches, & More
The Series 6 also features an always-on altimeter, so on hikes you can see the elevation change in real time on your watch face. Alongside Series 6, Apple announced the $279 (starting) Apple Watch SE and Series 3 will stay as the entry point at $199.
The Madrid hospitals of La Paz and La Princesa are, together with the Hospital Marqués de Valdecilla in Santander, the three centers participating in this clinical trial, which seeks to find the most appropriate dose and regimen to achieve the best antibody response. But we can not confirm whether how much it's going to affect the Oxford vaccine's development. "These surfaces are specialised and produce a different immune response to the rest of the body, so it is critical we explore whether targeting the airways directly can provide an effective response compared to a vaccine injected into muscle".
The EU has agreed to buy 400 million doses of the vaccine, with 30 million earmarked for Spain.
Mike Ryan, head of the World Health Organization's emergency department, said that this was not a competition between vaccine manufacturers or countries, but only to save lives. Phase 3 clinical trial of this vaccine was going on in 60 locations including America, Brazil, South Africa, India.
Scott Morrison touring the Astra Zeneca facility in NSW where a vaccine for COVID-19 is being produced.
The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19.